The invention is related to vacuum assisted treatments of the skin, and more particularly to creating a partial vacuum over the skin using a chamber positioned adjacent a surface of the skin in a target region.
Vacuum assisted treatment of the skin has recently been described in several patent applications, including: U.S. patent application Ser. No. 11/498,456; U.S. patent application Ser. No. 11/401,674; EP Patent Application No. 050007952.4; U.S. patent application Ser. No. 11/057,542; U.S. patent application Ser. No. 10/498,382; and PCT/IL02/00635, the disclosures of which are herein incorporated by reference in their entirety. Clinical applications of vacuum assisted treatments of the skin include, among others, light based aesthetic treatments of the skin such as hair removal, treatment of pigmented lesions, and treatment of vascular lesions as well as medical treatments such as painless injections. An evacuation chamber, which is currently utilized for pain reduction as well as to increase efficacy and safety of light based aesthetic treatments, can use a micro-switch to enable the generation of vacuum in the evacuation chamber. When the operator places the chamber contacts the skin on the treatment site, the switch is depressed and the air is removed from the vacuum chamber. This can be achieved by slightly pressing the skin while placing the evacuation chamber over the treatment site, resulting in the activation of the micro-switch and the activation of the vacuum.
Although generally satisfactory, a disadvantage of the utilization of a micro-switch on the skin can result if the skin lacks stiffness or rigidity. While pressing the skin for the activation of the micro-switch, the skin can recede. The receding degree depends on the specific patient. Skin receding is particularly significant in obese patients or in soft areas such as the axilla or bikini line or the chin. As a result, the micro-switch may not be activated, and evacuation over the skin may not occur. Consequently, a treatment may be more difficult, or in certain circumstances, may not be feasible.
The invention features, in one embodiment, a vacuum assisted treatment device including a chamber that can be used to partially evacuate air over a target region of skin. The device need not push upon or against flexible skin when placed on or near the skin. Instead, the device senses when the chamber is adjacent or proximate the skin, and can begin to generate vacuum. Furthermore, the device can include a mechanism to deactivate the vacuum so that the device can be easily and rapidly moved between target regions.
In one aspect, the invention features a method of treating skin. The method includes removing air from inside a chamber positioned adjacent a surface of the skin in a target region. The air outside the chamber flows into the chamber. Impedance of the air flowing between a rim of the chamber and the skin surface causes the pressure inside the chamber to decrease relative to ambient. The pressure inside the chamber decreases to a threshold value. The rate of removal of the air from inside the chamber is increased upon sensing the threshold value. The rim of the chamber forms a substantially fluid tight seal with the skin surrounding the target region. The skin of the target region is drawn toward an inner surface of the chamber.
In another aspect, the invention features an apparatus for treating skin. The apparatus includes a chamber defined by a surface and a rim extending from the surface. A source of vacuum is in fluid communication with the chamber. The source of vacuum is capable of removing air from inside the chamber so that air outside the chamber flows into the chamber. Impedance of the air flowing between the rim of the chamber positioned adjacent the skin surface causes the pressure inside the chamber to decrease relative to ambient. A pressure sensor is in fluid communication with the chamber. The pressure sensor determines when the pressure inside the chamber decreases to a threshold value. A controller is in electrical communication with the source of vacuum and the pressure sensor. The controller receives a signal from the pressure sensor when the threshold value is reached, which causes the rate of removal of the air from inside the chamber by the source of vacuum to be increased. The rim of the chamber forms a substantially fluid tight seal with the skin. The skin is drawn toward an inner surface of the chamber.
In yet another aspect, the invention features an apparatus for treating skin. The apparatus includes means for removing air from inside a chamber positioned adjacent a surface of the skin in a target region. The air outside the chamber flows into the chamber. Impedance of the air flowing between a rim of the chamber and the skin surface causes the pressure inside the chamber to decrease relative to ambient. The apparatus includes means for sensing pressure inside the chamber decreasing to a threshold value. The apparatus includes means for increasing the rate of removal of the air from inside the chamber upon sensing the threshold value. The rim of the chamber forms a substantially fluid tight seal with the skin surrounding the target region. The skin of the target region is drawn toward an inner surface of the chamber.
In other examples, any of the aspects above, or any apparatus or method described herein, can include one or more of the following features.
In various embodiments, electromagnetic radiation is delivered to treat the skin of the target region. An energy source can provide treatment radiation. The energy source can be in electrical communication with the controller, which triggers the energy source to deliver treatment radiation upon decreasing the pressure inside the chamber to a second threshold value. The surface of the chamber can include a transparent window, and the treatment radiation is delivered through the transparent window to the target region of skin. In some embodiments, the surface of the chamber includes a translucent window that causes at least a portion of the treatment radiation to be diffused as the treatment radiation is delivered to the target region of skin.
In some embodiments, the skin is drawn into contact with the inner surface of the chamber. A pressure sensor in fluid communication with the chamber can be used to sense the pressure inside the chamber. The chamber can be positioned one or more of near, adjacent, or proximate the surface of the skin. In certain embodiments, the chamber can be positioned about 0.01 mm to about 3 mm from the surface of the skin before the rate of removal of air is increased. In certain embodiments, the chamber can be positioned in contact with the surface of the air before the rate of removal of air is increased without creating a substantially fluid tight seal.
In various embodiments, the rate of removal of the air from inside the chamber can be modulated by repeatedly turning on and off a source of vacuum in fluid communication with the chamber. The rate of removal of the air from inside the chamber can be increased using a second source of vacuum. The second source of vacuum can be in fluid communication with the chamber and electrical communication with a controller, which can activate the second source of vacuum when the threshold value is reached.
The chamber can be capable of forming the substantially fluid tight seal between the rim of the chamber and soft skin. The substantially fluid tight seal can be released by decreasing the rate of removal of the air from inside the chamber after a predetermined time interval following achieving the threshold value. The rate of removal of air can be decreased using a mechanism that introduces air into the chamber. In some embodiments, the substantially fluid tight seal can be released by introducing air into the chamber after a predetermined time interval following achieving the threshold value. The apparatus can include a distance gauge to facilitate placement of the chamber at, adjacent, near, or proximate to the skin. In certain embodiments, an index matching layer can be disposed on an outer surface of the chamber to facilitate delivery of the electromagnetic radiation.
In certain embodiments, a lubricant can be disposed on a surface of the skin, and the lubricant can be used to facilitate movement of the chamber to a second target region of the skin. In some embodiments, an index matching layer is disposed on a surface of the skin to facilitate delivery of the electromagnetic radiation treating the skin.
In various embodiments, a treatment can be provided for one or more of hair removal, pigmented lesions, tattoo removal, lipid rich tissue, vascular lesions, acne, skin tightening, skin remodeling, and skin rejuvenation. In certain embodiments, an injection can be delivered through a surface of the chamber into the skin to provide a vaccine, collagen, insulin, or botox. An injector (e.g., a needle or syringe) can be used.
Other aspects and advantages of the invention will become apparent from the following drawings and description, all of which illustrate the principles of the invention, by way of example only.
The foregoing and other objects, feature and advantages of the invention, as well as the invention itself, will be more fully understood from the following illustrative description, when read together with the accompanying drawings which are not necessarily to scale.
The apparatus 10 can provide vacuum to partially evacuate the chamber 14 positioned at or near the skin. The apparatus 10 can be used in light based aesthetic treatments as well as in other skin treatments including injections, ultrasound treatments, and other vacuum assisted treatments. An injector is described in U.S. patent application Ser. No. 11/498,456, herein incorporated by reference in its entirety. An injection can include one or more of vaccines, mesotherapy, collagen injections, insulin injections, botox injections, intramuscular injections, and dermal injections.
The chamber 14 can compress and flatten the treated elevated skin as a result of partially evacuating the chamber.
In certain embodiments, a lubricant can be disposed on a surface of the skin, and the lubricant can be used to facilitate movement of the chamber to a second target region of the skin. A sapphire translucent window can preserve its translucent properties even if residual lubricant is present on its diffusing surface, which may be in contact with the skin. This is advantageous since a diffusing window is eye safe. Before firing a treatment pulse, the lubricant, or at least a portion thereof, can be removed from the surface of the skin by the vacuum.
Once valve 44b is open, the vacuum level achieved in the chamber 41 can reach 50 millibars-1000 millibars, depending on a preset value and the opening level of valve 44b. Normally, the vacuum level is preset to 600-700 millibars. Pain inhibition by gate theory, as described in U.S. patent application Ser. No. 11/498,456, for example, is attained at 400-1000 millibars of pressure below ambient. Once valve 44b is opened and vacuum is set in chamber 41, the skin is drawn toward the chamber and elevated. Drawing the skin toward the surface of the chamber can be referred to as automatic generation of vacuum because a microswitch or other initiator is not used to generate the vacuum when the chamber is placed proximate to the skin surface.
The skin can be spaced from the surface or window of the chamber, or the skin can contact the surface or window of the chamber. A substantially fluid tight seal can be achieved between the rim of the chamber and the skin surface. In some embodiments, a substantially fluid tight seal is achieved between the surface of the target region of skin and/or the chambers walls. The seal can be improved by applying to the skin a lubricating fluid such as gel, oil or water. The lubricating fluid can include a detergent.
An evacuation chamber can be operated at a rapid rate of about 0.6 sec between treatment pulses while gliding on skin (e.g., obese skin) without the skin receding. Skin receding can be prevented because the chamber need not be pressed into the skin to initiate the vacuum.
In certain embodiments, the light source 52 can be attached to the evacuation chamber 41. For example, the evacuation chamber 41 can be attached to the distal end of a handpiece used to deliver light from the light source 52. For example, the evacuation chamber 41 can be integrated into the handpiece. In other embodiments, the light source 52 and the evacuation chamber 41 are removable from one another. For example, the evacuation chamber 41 can be attachable to a handpiece used to deliver light from the light source 52. For example, the evacuation chamber 41 can be an attachment for the handpiece.
In various embodiments, the size of the window of evacuation chamber is about 10 mm and 100 mm, although larger or smaller windows can be used depending on the application.
In various embodiments, the level of vacuum during a treatment is about 100-1000 millibars, although larger or smaller values can be used depending on the application.
In various embodiments, the level of vacuum for initiation of high vacuum level is about 10-100 millibars, although larger or smaller values can be used depending on the application.
In various embodiments, the vacuum can be modulated from no modulation (0 Hz) to about 1000 Hz, although larger or smaller values can be used depending on the application. Vacuum modulation can result from repetitively turning on and off a vacuum valve (e.g., valve 44a or 44b).
In various embodiments, the height of the chamber is about 1-40 mm, although larger or smaller values can be used depending on the application. The lateral size (parallel to the skin) of the chamber can be larger than 10 mm.
In various embodiments, the chamber is positioned adjacent the skin before the deeper vacuum (e.g., before the rate of removal is increased) is applied. The chamber can be positioned about 0.01 mm and about 10 mm from the skin, although larger or smaller distances can be used depending on the application. The chamber can be positioned about 0.01 mm and about 3 mm from the skin. In some embodiments, the chamber is lightly touching the surface of the skin before the deeper vacuum is applied.
In various embodiments, the time duration of treatment vacuum is about 0.1-15 seconds, although larger or smaller values can be used depending on the application.
In various embodiments, the treatment fluence is about 0.1 Joules/cm2-500 Joules/cm2, although larger or smaller fluences can be used depending on the application.
In various embodiments, the treatment pulse duration can be about 1 ns to 30 seconds, although larger or smaller pulse durations can be used depending on the application.
In various embodiments, a treatment beam can be moved between treatment regions at a rate faster than 0.2-2 spots per second, although larger or smaller rates can be used depending on the application.
In various embodiments, the skin can be elevated within about 0.1 sec to 1 sec after applying deeper vacuum.
In various embodiments, the thickness of the index matching layer is about 10 mm-1000 mm, although larger or smaller thickness can be used depending on the application. In some embodiments, the thickness is about 0.01 mm-3 mm.
In various embodiments, the IPL lamp can be a xenon, krypton, or halogen lamp. In various embodiments, the size of the IPL capsule is about 15-40 mm by 15-40 mm by 30-100 mm.
In various embodiments, a mechanism is used to introduce air to break the vacuum seal between the chamber and the skin. In certain embodiments, the flattened skin can become stuck to the surface of the chamber or chamber window. A vacuum release mechanism can facilitate removal of the skin from the chamber surface or chamber window. The mechanism can be located at least 1 meter from the vacuum chamber and pressure inside the chamber can be restored to ambient in less than about 0.5 seconds.
In various embodiments, the mechanism can be a compression pump remote from the located chamber. The compression pump can be about 1-3 meters from the chamber. Tubing connecting the compression pump to the chamber is evacuated during a treatment. With a 3 mm diameter tubing, the additional volume can be more than 5 times the vacuum chamber volume, resulting in a large pump or release time which is longer than 0.5 seconds. This can slow down the total treatment process time, since an application of 1000 pulses over a back can increase the total treatment time by about 500 seconds. By turning on the pressure release 0.3 seconds prior to the termination of the evacuation mode, skin flattening is gradually diminishing; however, the pain blocking effect can still be active. As a result, vacuum release time is effectively reduced without compromising pain blocking. In certain embodiments, the mechanism is capable of capable of vacuum release within a duration smaller than 0.5 sec whereby the vacuum release (e.g., a pump or valve) is located at a distance greater than 1 meter from the skin.
In various embodiments, a system for treating skin can be used for one or more of hair removal, treatment of pigmented lesions, treatment or removal of a tattoo, treatment of fat, treatment of vascular lesions, treatment of acne, skin tightening, skin remodeling, skin rejuvenation, and wrinkle treatments, although other indications can be treated as well.
In various embodiments, the target region can include one or more of an axilla, an underarm, a bikini line, a chin, a region of soft tissue, or a region of fatty tissue. Other target regions can be treated using the technology.
While the invention has been particularly shown and described with reference to specific illustrative embodiments, it should be understood that various changes in form and detail may be made without departing from the spirit and scope of the invention.
Number | Name | Date | Kind |
---|---|---|---|
3982541 | L'Esperance, Jr. | Sep 1976 | A |
4592353 | Daikuzono | Jun 1986 | A |
4736743 | Daikuzono | Apr 1988 | A |
4838281 | Rogers et al. | Jun 1989 | A |
4976709 | Sand | Dec 1990 | A |
5057104 | Chess | Oct 1991 | A |
5059192 | Zaias | Oct 1991 | A |
5066293 | Furumoto | Nov 1991 | A |
5217455 | Tan | Jun 1993 | A |
5226907 | Tankovich | Jul 1993 | A |
5282797 | Chess | Feb 1994 | A |
5312395 | Tan et al. | May 1994 | A |
5344418 | Ghaffari | Sep 1994 | A |
5401270 | Müller et al. | Mar 1995 | A |
5411502 | Zair | May 1995 | A |
5429601 | Conley et al. | Jul 1995 | A |
5431647 | Purcell, Jr. et al. | Jul 1995 | A |
5449354 | Konwitz et al. | Sep 1995 | A |
5527308 | Anderson et al. | Jun 1996 | A |
5530780 | Ohsawa | Jun 1996 | A |
5558660 | Dreier | Sep 1996 | A |
5595568 | Anderson et al. | Jan 1997 | A |
5626631 | Eckhouse | May 1997 | A |
5630811 | Miller | May 1997 | A |
5655547 | Karni | Aug 1997 | A |
5735844 | Anderson et al. | Apr 1998 | A |
5745519 | Ruda et al. | Apr 1998 | A |
5814041 | Anderson et al. | Sep 1998 | A |
5853407 | Miller | Dec 1998 | A |
5871521 | Kaneda et al. | Feb 1999 | A |
5879346 | Waldman et al. | Mar 1999 | A |
5885273 | Eckhouse et al. | Mar 1999 | A |
5947957 | Morris | Sep 1999 | A |
5961475 | Guitay | Oct 1999 | A |
5964749 | Eckhouse et al. | Oct 1999 | A |
6011890 | Neuberger | Jan 2000 | A |
6096029 | O'Donnell, Jr. | Aug 2000 | A |
6120497 | Anderson et al. | Sep 2000 | A |
6132392 | Stone | Oct 2000 | A |
6142650 | Brown et al. | Nov 2000 | A |
6149645 | Tobinick | Nov 2000 | A |
6165170 | Wynne et al. | Dec 2000 | A |
6185356 | Parker et al. | Feb 2001 | B1 |
6197020 | O'Donnell, Jr. | Mar 2001 | B1 |
6214034 | Azar | Apr 2001 | B1 |
6261310 | Neuberger et al. | Jul 2001 | B1 |
6264649 | Whitcroft et al. | Jul 2001 | B1 |
6273884 | Altshuler et al. | Aug 2001 | B1 |
6280438 | Eckhouse et al. | Aug 2001 | B1 |
6508813 | Altshuler | Jan 2003 | B1 |
6530920 | Whitcroft et al. | Mar 2003 | B1 |
6544259 | Tsaliovich | Apr 2003 | B1 |
6562050 | Owen | May 2003 | B1 |
6662054 | Kreindel et al. | Dec 2003 | B2 |
7108689 | Eckhouse et al. | Sep 2006 | B2 |
7184614 | Slatkine | Feb 2007 | B2 |
20020012860 | Yoo | Jan 2002 | A1 |
20020013602 | Huttner | Jan 2002 | A1 |
20020034012 | Santoro et al. | Mar 2002 | A1 |
20020128600 | Nissels | Sep 2002 | A1 |
20020128635 | Altshuler et al. | Sep 2002 | A1 |
20020169442 | Neev | Nov 2002 | A1 |
20030083536 | Eshel et al. | May 2003 | A1 |
20040077977 | Ella et al. | Apr 2004 | A1 |
20040082940 | Black et al. | Apr 2004 | A1 |
20040254599 | Lipoma et al. | Dec 2004 | A1 |
20050147137 | Slatkine | Jul 2005 | A1 |
20050215987 | Slatkine | Sep 2005 | A1 |
20050234527 | Slatkine | Oct 2005 | A1 |
20050251117 | Anderson et al. | Nov 2005 | A1 |
20050251118 | Anderson et al. | Nov 2005 | A1 |
20050261584 | Eshel et al. | Nov 2005 | A1 |
20060013533 | Slatkine | Jan 2006 | A1 |
20060189964 | Anderson et al. | Aug 2006 | A1 |
20060211958 | Rosenberg et al. | Sep 2006 | A1 |
20060241573 | Roersma et al. | Oct 2006 | A1 |
20060259102 | Slatkine | Nov 2006 | A1 |
20060293722 | Slatkine et al. | Dec 2006 | A1 |
20070027411 | Ella et al. | Feb 2007 | A1 |
20070032763 | Vogel | Feb 2007 | A1 |
20070179482 | Anderson | Aug 2007 | A1 |
20070219532 | Karpowicz et al. | Sep 2007 | A1 |
20070230520 | Mordaunt et al. | Oct 2007 | A1 |
20070255355 | Altshuler et al. | Nov 2007 | A1 |
20080119830 | Kamstad et al. | May 2008 | A1 |
20080123342 | Gluszczak et al. | May 2008 | A1 |
20080215039 | Slatkine | Sep 2008 | A1 |
Number | Date | Country |
---|---|---|
37 30 469 | Jun 1988 | DE |
198 49 301 | Apr 2000 | DE |
0 103 664 | Mar 1984 | EP |
0 761 257 | Mar 1997 | EP |
0 880 940 | Dec 1998 | EP |
0 933 096 | Aug 1999 | EP |
1 031 324 | Aug 2000 | EP |
1 116 476 | Jul 2001 | EP |
1 168 535 | Jan 2002 | EP |
1 494 324 | Dec 1977 | GB |
2001-212231 | Aug 2001 | JP |
2005-87520 | Apr 2005 | JP |
9927863 | Jun 1999 | WO |
9946005 | Sep 1999 | WO |
0060711 | Oct 2000 | WO |
0072771 | Dec 2000 | WO |
0137922 | May 2001 | WO |
03049633 | Jun 2003 | WO |
03103523 | Dec 2003 | WO |
2004004803 | Jan 2004 | WO |
2005009266 | Feb 2005 | WO |
2005112815 | Dec 2005 | WO |
2006052745 | May 2006 | WO |
2007015247 | Feb 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20090088823 A1 | Apr 2009 | US |